Ogilvie syndrome primary prevention

Jump to navigation Jump to search
Ogilvie syndrome Microchapters


Patient Information


Historical Perspective




Differentiating Ogilvie syndrome from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


History and Symptoms

Physical Examination

Laboratory Findings

X Ray




Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ogilvie syndrome primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Ogilvie syndrome primary prevention

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ogilvie syndrome primary prevention

CDC on Ogilvie syndrome primary prevention

Ogilvie syndrome primary prevention in the news

Blogs on Ogilvie syndrome primary prevention

Directions to Hospitals Treating Ogilvie syndrome

Risk calculators and risk factors for Ogilvie syndrome primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]


Effective measures for the primary prevention of Ogilvie syndrome include supportive care measures as treatment of the underlying cause of the obstruction, terminating the concurrent medications that may cause intestinal dysmotility, and administration of intravenous fluids and saline.

Ogilvie syndrome

  • Supportive care is recommended in patients with colonic pseduo-obstruction in order to prevent the development of serious complications like intestinal perforation. It can be performed in the first few days after diagnosing the colonic pseudo-obstruction as long as there is no severe pain or extreme abdominal distension.[1]
  • The supportive measures include the following:[2]
    • Following up of any underlying cause like heart failure or infection
    • Terminating any concurrent medication that may cause intestinal dysmotility like opoids and calcium channel blockers
    • Administration of intravenous saline and fluids in order to preserve the normal body homeostasis
    • Placement of the patients in a prone position with elevation of the hips


  1. Eisen GM, Baron TH, Dominitz JA, Faigel DO, Goldstein JL, Johanson JF; et al. (2002). "Acute colonic pseudo-obstruction". Gastrointest Endosc. 56 (6): 789–92. PMID 12447286.
  2. Sloyer AF, Panella VS, Demas BE, Shike M, Lightdale CJ, Winawer SJ; et al. (1988). "Ogilvie's syndrome. Successful management without colonoscopy". Dig Dis Sci. 33 (11): 1391–6. PMID 3180976.